期刊
JOURNAL OF NEURORADIOLOGY
卷 46, 期 5, 页码 281-287出版社
MASSON EDITEUR
DOI: 10.1016/j.neurad.2019.05.013
关键词
Magnetic resonance imaging; Meningioma; Haemangiopericytoma; Machine-learning; Support vector machine
资金
- National Natural Science Foundation of China [81501435]
- Shanghai Sailing Program [18YF1403000]
- Shanghai Natural Science Foundation [18ZR1405700]
- Science and Technology Commission of Shanghai Municipality [16410722800, 17411953700]
Purpose. - To assess whether a machine-learning model based on texture analysis (TA) could yield a more accurate diagnosis in differentiating malignant haemangiopericytoma (HPC) from angiomatous meningioma (AM). Materials and methods. - Sixty-seven pathologically confirmed cases, including 24 malignant HPCs and 43 AMs between May 2013 and September 2017 were retrospectively reviewed. In each case, 498 radiomic features, including 12 clinical features and 486 texture features from MRI sequences (T2-FLAIR, DWI and enhanced T1WI), were extracted. Three neuroradiologists independently made diagnoses by vision. Four Support Vector Machine (SVM) classifiers were built, one based on clinical features and three based on texture features from three MRI sequences after feature selection. The diagnostic abilities of these classifiers and three neuroradiologists were evaluated by receiver operating characteristic (ROC) analysis. Results. - Malignant HPCs were found to have larger sizes, slighter degrees of peritumoural oedema compared with AMs (P < 0.05), and more serpentine-like vessels. The AUC of the enhanced T1WI-based classifier was 0.90, significantly higher than that of T2-FLAIR-based or DWI-based classifiers (0.77 and 0.73). The AUC of the SVM classifier based on clinical features was 0.66, slightly but not significantly lower than the performances of 3 neuroradiologists (AUC = 0.69, 0.70 and 0.73). Conclusion. - Machine-learning models based on clinical features alone could not provide a better diagnostic performance than that of radiologists. The SVM classifier built by texture features extracted from enhanced T1WI is a promising tool to differentiate malignant HPC from AM before surgery. (C) 2019 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据